Bob Doll: Trump Adds to Corrective Noise in Health Stocks

Bob Doll, chief equity strategist at Nuveen Asset Management, discusses concern around health care stocks and why he's a buyer of biotech on weakness. He speaks on "Bloomberg Daybreak: Americas." (Source: Bloomberg)

Full Show: What'd You Miss? (08/17)
04:53 - Guests include: Eurasia Group's Federico Santi, BMO Capital's Brian Belski, Geopolitical Futures founder George Friedman and Goldman Sachs & Co.'s Gary Chropuvka. (Source: Bloomberg)
  • Alibaba Sales, Profit Top Estimates
  • Bloomberg Markets: The Trump Economy 8/17/2017
  • Full Show: Bloomberg Daybreak: Americas (08/17)